Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight > 100 kg: Pooled Data From 3 Randomized Clinical Trials

The ASA/AHA guidelines recommend a fixed dose of 90 mg of intravenous (IV) recombinant tissue plasminogen activator (rt-PA) for acute stroke patients weighing more than 100 kg. We aimed to determine if body weight>100 kg (and receiving

Source: Journal of Stroke and Cerebrovascular Diseases - August 1, 2018 Category: Neurology Authors: Shahram Majidi, Christopher R. Leon Guerrero, Kathleen M. Burger, Dimitri Sigounas, Wayne J. Olan, Adnan I. Qureshi Source Type: research